Chronic Suppurative Otitis Media
On this page
Direct answer
Chronic suppurative otitis media means ear discharge through a permanent tympanic membrane perforation lasting more than three months, and Indian teaching splits it into a safe tubotympanic type and an unsafe atticoantral type. The tubotympanic type shows a central, usually anteroinferior perforation with mucosal disease and mild conductive loss, and is treated with aural toilet, topical quinolone drops and, once dry, myringoplasty. The atticoantral type involves a posterosuperior or attic defect with squamous epithelium and cholesteatoma that erodes bone, and it demands mastoid surgery — a modified radical mastoidectomy — because it threatens complications.
What you must remember
- Safe (tubotympanic, mucosal): central perforation, mucoid discharge, mild conductive hearing loss, low complication risk.
- Unsafe (atticoantral, squamous): posterosuperior marginal or attic perforation with cholesteatoma, foul scanty discharge, bone erosion, sensorineural involvement and grave intracranial risk.
- A central perforation retains a rim of drum all around; a marginal perforation reaches the annulus — the single otoscopic finding that changes management.
- Active discharge is treated with dry mopping plus topical ciprofloxacin drops; topical aminoglycosides are avoided with a perforation because of ototoxicity risk.
- Surgery for the dry safe ear is myringoplasty (closing the hole) or tympanoplasty (with ossicular reconstruction); the unsafe ear gets a modified radical mastoidectomy, with canal-wall-up combined-approach surgery in selected centres.
- Tuberculous otitis media, worth remembering in India, gives painless copious discharge, multiple perforations, pale granulations and sometimes facial palsy, responding only to antitubercular therapy.
- Any CSOM with vertigo, facial weakness, severe headache or worsening hearing has developed a complication and needs urgent imaging, not drops.
Safe versus unsafe: a reasoned comparison
Both types begin with Eustachian tube failure, but their natural histories diverge because of where the perforation sits. In the tubotympanic type, infection enters through a central defect into well-ventilated middle-ear mucosa; discharge is profuse during colds but the disease stays mucosal, like a stubborn skin infection that never invades bone. Hearing loss is purely conductive, usually 20 to 40 decibels, because the ossicular chain survives. Management therefore aims at hygiene and closure: dry the ear with aural toilet and quinolone drops, treat rhinitis and adenoid disease, wait for six dry weeks, then close the perforation so reinfection and swimming no longer matter. The ear is "safe" precisely because complications are rare when the perforation is central.
The atticoantral type behaves like a tumour of skin. Squamous epithelium migrates through an attic or posterosuperior marginal defect into the epitympanum and mastoid antrum, sheds keratin that cannot escape, and the resulting cholesteatoma sac secretes collagenases and interleukin-1 that quietly dissolve ossicles and the labyrinthine capsule. That is why this ear presents not with floods of mucus but with scanty, foul, recurrent discharge, a pearly mass or granulations in the attic, and hearing loss that may turn sensorineural as the inner ear is breached. No drop can reach a keratin sac in the antrum; only complete surgical excision with a modified radical mastoidectomy, creating a safe, clean, self-cleaning cavity, removes the threat of labyrinthine fistula, facial palsy, abscess and meningitis. Comparing the two trains you to look at one otoscopic finding — where the perforation is — and predict the entire disease behaviour.
Where students slip
Two errors recur in viva and MCQ answers alike. The first is calling every discharging ear "CSOM, treat with drops" without locating the perforation: an attic or posterosuperior defect with pearly flakes is unsafe disease that drops cannot cure, and delayed surgery is how patients arrive with facial palsy. The second is choosing gentamicin or neomycin drops for a perforated, discharging ear; the examinable answer is ciprofloxacin, which is not ototoxic. Add the Indian favourite: painless discharge with multiple perforations and pale granulation in a poorly nourished child should prompt suspicion of tuberculous otitis and biopsy, not another course of empirical antibiotics.
Frequently asked questions
What distinguishes tubotympanic from atticoantral CSOM?
A central anteroinferior perforation with mucosal disease and mild conductive loss (safe) versus a posterosuperior or attic defect with cholesteatoma, bone erosion and complication risk (unsafe).
Which ear drops are safe in a perforated, discharging ear?
Topical quinolones such as ciprofloxacin, often with a steroid; aminoglycoside drops risk cochlear ototoxicity through the round window.
What operations are done for each type?
Myringoplasty or tympanoplasty for the dry tubotympanic ear; modified radical mastoidectomy (canal wall down) or combined-approach tympanomastoidectomy for the atticoantral ear.
When should tuberculous otitis media be suspected?
Painless copious discharge with multiple perforations, pale granulations, failing response to routine treatment, or facial palsy, confirmed by biopsy and treated with antitubercular therapy.
Which CSOM features signal an impending complication?
Vertigo with a positive fistula test, facial nerve palsy, severe headache with vomiting, or rapidly worsening hearing — each warrants urgent imaging and surgical intervention.